Pustular Psoriasis - 29 Studies Found
Completed |
: Study to Assess the Efficacy, Safety and Tolerability of Secukinumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP) : Psoriasis : 2013-09-24 : Biological: Secukinumab Secukinumab 150 mg, provided in a 1 mL prefilled syringe (one syringe for 150 mg |
Recruiting |
: BI655130 Single Dose in Generalized Pustular Psoriasis : Psoriasis : 2016-11-29 : Drug: BI655130 |
Recruiting |
: A Study to Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic Psoriasis :
|
Completed |
: An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis : Psoriasis : 2013-01-27 : Drug: KHK4827 140 mg (dosage may be increased to 210 mg in case of insufficient efficacy) |
Completed |
: A Phase 3 Clinical Study of KHK 4827 :
|
Completed |
: A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis :
|
Completed |
: Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis :
|
Recruiting |
: Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases :
|
COMPLETED |
: HB0034 in Patients With Generalized Pustular Psoriasis (GPP) : Generalized Pustular Psoriasis : 2024-05-11 : HB0034, a single dose |